Differential Diagnoses for Adenoid Cystic Carcinoma Patterns
The differential diagnosis for adenoid cystic carcinoma (ACC) depends critically on the histologic pattern: Type 1 (cribriform/tubular) must be distinguished from polymorphous low-grade adenocarcinoma, basaloid squamous cell carcinoma, and colonic/intestinal adenomas with cribriform architecture, while Type 2 (solid) requires differentiation from basaloid squamous cell carcinoma, small cell carcinoma, and poorly differentiated adenocarcinoma.
Type 1 (Cribriform/Tubular Pattern) Differentials
Primary Differential: Polymorphous Low-Grade Adenocarcinoma (PLGA)
The cribriform pattern in ACC creates the most diagnostic confusion with PLGA, as both share similar architectural features 1. However, the cellular composition is fundamentally different and distinguishable by immunohistochemistry:
- ACC cribriform spaces: Surrounded by cells negative for cytokeratins (7,8,14,19) and integrins (β1, β3, β4), representing myoepithelial cells 1
- PLGA cribriform areas: Composed of cords of luminal cells positive for cytokeratins with bipolar integrin distribution 1
- ACC consistently expresses: CD117 (100%), p63 (100%), and S-100 protein (90%) 2, 3
Basaloid Squamous Cell Carcinoma
This is a critical differential, particularly in esophageal and head/neck locations 2:
- Distinguishing features for ACC: Dual ductal and myoepithelial differentiation, myxoid stromal degeneration, consistent CD117 and S-100 positivity
- Basaloid SCC: Lacks true glandular/ductal structures, shows more peripheral palisading, negative for S-100 protein
- Key pitfall: Both may show comedo-type necrosis (seen in 80% of esophageal ACC) 2
High-Grade Intestinal Neoplasia with Cribriform Pattern
When evaluating cribriform architecture in gastrointestinal contexts 4:
- High-grade dysplasia/GIN: Shows cribriform structures with marked reduction of interglandular stroma, back-to-back glands, loss of nuclear polarity
- ACC: Maintains dual cell population (ductal + myoepithelial), shows CK7+/CK20- pattern (opposite of colorectal origin), CD117 positive
Type 2 (Solid Pattern) Differentials
Small Cell Carcinoma
This is the most critical differential for solid ACC 2:
- ACC solid variant: Retains focal ductal structures, maintains CD117 and p63 positivity, shows myoepithelial markers
- Small cell carcinoma: Shows neuroendocrine markers (chromogranin, synaptophysin), TTF-1 positive in lung primaries, Ki-67 proliferation index 50-70% 5
- Definitive distinction: ACC lacks neuroendocrine differentiation and has much lower proliferative index
Poorly Differentiated Adenocarcinoma
Solid ACC can mimic poorly differentiated adenocarcinoma 6:
- ACC: Even in solid areas, maintains some tubular/ductal elements, dual cell population on immunohistochemistry, myxoid stroma
- Poorly differentiated adenocarcinoma: Lacks myoepithelial component, shows single cell population, typically higher grade nuclear features
Mucoepidermoid Carcinoma
Particularly relevant in salivary gland locations 2:
- ACC: Lacks true squamous differentiation and mucin-producing cells intermixed, shows consistent CD117 expression
- Mucoepidermoid: Contains distinct populations of mucous, intermediate, and epidermoid cells, variable CD117 expression
Diagnostic Algorithm
Step 1: Identify growth pattern (cribriform/tubular vs solid) and assess for dual cell population (ductal + myoepithelial)
Step 2: Apply minimal immunohistochemical panel:
- CD117 (should be diffusely positive in ACC)
- p63 (marks myoepithelial cells)
- S-100 protein (positive in 90% of ACC)
- CK7 (marks ductal structures)
Step 3: If solid pattern, add:
- Neuroendocrine markers (chromogranin, synaptophysin) to exclude small cell carcinoma
- Ki-67 proliferation index (ACC typically <20%, small cell >50%)
Step 4: If cribriform pattern with diagnostic uncertainty:
- Assess integrin distribution pattern (apical in ACC microcysts, bipolar in PLGA) 1
- Evaluate for myxoid stromal degeneration (favors ACC)
Critical Pitfalls to Avoid
- Do not rely on architecture alone: Cribriform patterns occur in multiple entities; cellular composition and immunophenotype are definitive 1
- Recognize site-specific mimics: Esophageal ACC may show squamous dysplasia or focal squamous carcinoma (30% of cases), which does not exclude ACC diagnosis 2
- Avoid overdiagnosis of solid ACC as high-grade carcinoma: Despite solid architecture, ACC maintains relatively organized growth and dual differentiation 3
- Remember molecular confirmation: MYB-NFIB or MYBL1-NFIB fusion is present in most ACC and can be definitive when morphology and immunohistochemistry are equivocal 3